We used highly purified avian osteoclasts and isolated membranes from osteoclasts to study effects of tamoxifen, 4-hydroxytamoxifen, calmodulin antagonists, estrogen, diethylstilbestrol, and the anti-estrogen ICI 182780 on cellular degradation of H-labeled bone in vitro and on membrane HCl transport. Bone resorption was reversibly inhibited by tamoxifen, 4-hydroxytamoxifen, and trifluoperazine with IC values of 1 µM. Diethylstilbestrol and 17--estradiol had no effects on bone resorption at receptor-saturating concentrations, while ICI 182780 inhibited bone resorption at concentrations greater than 1 µM. At these concentrations ICI 182780, like tamoxifen, inhibits calmodulin-stimulated cyclic nucleotide phosphodiesterase activity. Membrane HCl transport, assessed by ATP-dependent acridine orange uptake, was unaffected by 17--estradiol and diethylstilbestrol at concentrations up to 10 µM, while ICI 182780 inhibited HCl transport at concentrations greater than 1 µM. In contrast HCl transport was inhibited by tamoxifen, 4-hydroxytamoxifen, and the calmodulin antagonists, trifluoperazine and calmidazolium, with IC values of 0.25-1.5 µM. These results suggested the presence of a membrane-associated non-steroid receptor for tamoxifen in osteoclasts. Tamoxifen binding studies demonstrated saturable binding in the osteoclast particulate fraction, but not in the nuclear or cytosolic fractions. Membranes enriched in ruffled border by differential centrifugation following nitrogen cavitation showed binding consistent with one site, K 1 µM. Our findings indicate that tamoxifen inhibits osteoclastic HCl transport by binding membrane-associated target(s), probably similar or related to calmodulin antagonist targets. Further, effects of estrogens or highly specific anti-estrogens on bone turnover do not support the hypothesis of a direct effect on osteoclasts by these compounds in this species.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				X. Wu, E.-Y. Ahn, M. A. McKenna, H. Yeo, and J. M. McDonald Fas Binding to Calmodulin Regulates Apoptosis in Osteoclasts J. Biol. Chem., August 19, 2005; 280(33): 29964 - 29970. [Abstract] [Full Text] [PDF]

				G. I. Gorodeski, U. Hopfer, C. C. Liu, and E. Margles Estrogen Acidifies Vaginal pH by Up-Regulation of Proton Secretion via the Apical Membrane of Vaginal-Ectocervical Epithelial Cells Endocrinology, February 1, 2005; 146(2): 816 - 824. [Abstract] [Full Text] [PDF]

				X. Wu, M. A. McKenna, X. Feng, T. R. Nagy, and J. M. McDonald Osteoclast Apoptosis: The Role of Fas in Vivo and in Vitro Endocrinology, December 1, 2003; 144(12): 5545 - 5555. [Abstract] [Full Text] [PDF]

				L. Zhang, X. Feng, and J. M. McDonald The Role of Calmodulin in the Regulation of Osteoclastogenesis Endocrinology, October 1, 2003; 144(10): 4536 - 4543. [Abstract] [Full Text] [PDF]

				Q. Wang, Y. Xie, Q.-S. Du, X.-J. Wu, X. Feng, L. Mei, J. M. McDonald, and W.-C. Xiong Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin J. Cell Biol., February 18, 2003; 160(4): 565 - 575. [Abstract] [Full Text] [PDF]

				V. Parikka, P. Lehenkari, M.-L. Sassi, J. Halleen, J. Risteli, P. Harkonen, and H. K. Vaananen Estrogen Reduces the Depth of Resorption Pits by Disturbing the Organic Bone Matrix Degradation Activity of Mature Osteoclasts Endocrinology, December 1, 2001; 142(12): 5371 - 5378. [Abstract] [Full Text] [PDF]

				K. J. Micoli, G. Pan, Y. Wu, J. P. Williams, W. J. Cook, and J. M. McDonald Requirement of Calmodulin Binding by HIV-1 gp160 for Enhanced FAS-mediated Apoptosis J. Biol. Chem., January 14, 2000; 275(2): 1233 - 1240. [Abstract] [Full Text] [PDF]

				Y. Chen, M. Schindler, and S. M. Simon A Mechanism for Tamoxifen-mediated Inhibition of Acidification J. Biol. Chem., June 25, 1999; 274(26): 18364 - 18373. [Abstract] [Full Text] [PDF]

				V. Kusec, A. S. Virdi, R. Prince, and J. T. Triffitt Localization of Estrogen Receptor-{alpha} in Human and Rabbit Skeletal Tissues J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2421 - 2428. [Abstract] [Full Text]